2023
DOI: 10.3390/v15071429
|View full text |Cite
|
Sign up to set email alerts
|

Acetate-encapsulated Linolenic Acid Liposomes Reduce SARS-CoV-2 and RSV Infection

Abstract: Emergent Coronaviridae viruses, such as SARS-CoV-1 in 2003, MERS-CoV in 2012, and SARS-CoV-2 (CoV-2) in 2019, have caused millions of deaths. These viruses have added to the existing respiratory infection burden along with respiratory syncytial virus (RSV) and influenza. There are limited therapies for respiratory viruses, with broad-spectrum treatment remaining an unmet need. Since gut fermentation of fiber produces short-chain fatty acids (SCFA) with antiviral potential, developing a fatty acid-based broad-s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 75 publications
(110 reference statements)
0
1
0
Order By: Relevance
“…The studies evaluating a direct effect of ALA against SARS‐CoV‐2 are limited in number, with only one specifically focusing on its potential anti‐inflammatory and immunomodulatory properties. In this study, conducted on a murine model, a substantial reduction in lung inflammation, cytokine expression, and a significant decrease in viral plaque‐forming units were observed (McGill et al., 2023).…”
Section: Introductionmentioning
confidence: 76%
“…The studies evaluating a direct effect of ALA against SARS‐CoV‐2 are limited in number, with only one specifically focusing on its potential anti‐inflammatory and immunomodulatory properties. In this study, conducted on a murine model, a substantial reduction in lung inflammation, cytokine expression, and a significant decrease in viral plaque‐forming units were observed (McGill et al., 2023).…”
Section: Introductionmentioning
confidence: 76%